Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Advances in understanding of the pathophysiology of rheumatoid arthritis with concurrent advances in protein engineering led to the development of biological disease-modifying antirheumatic drugs which have dramatically revolutionized the treatment of this condition. This review article focuses on the role of biological agents currently employed in the treatment of rheumatoid arthritis, as well as novel biological agents in development.

More information Original publication

DOI

10.1016/j.phrs.2019.104497

Type

Journal article

Publication Date

2019-12-01T00:00:00+00:00

Volume

150

Keywords

Biological disease-modifying antirheumatic drugs, Review, Rheumatoid arthritis, Animals, Antirheumatic Agents, Arthritis, Rheumatoid, Biological Factors, Humans